The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 08, 2025

Filed:

Mar. 30, 2023
Applicant:

Clearnote Health, Inc., San Mateo, CA (US);

Inventors:

Patrick A. Arensdorf, Palo Alto, CA (US);

Damek Spacek, Redwood City, CA (US);

Assignee:

ClearNote Health, Inc., San Diego, CA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/6806 (2018.01); C07H 19/06 (2006.01); C07H 21/04 (2006.01); C07J 1/00 (2006.01); C12Q 1/6827 (2018.01); C12Q 1/6869 (2018.01);
U.S. Cl.
CPC ...
C12Q 1/6806 (2013.01); C07H 19/06 (2013.01); C07H 21/04 (2013.01); C07J 1/00 (2013.01); C12Q 1/6827 (2013.01); C12Q 1/6869 (2013.01); C12Q 2523/10 (2013.01); C12Q 2523/115 (2013.01); C12Q 2537/164 (2013.01);
Abstract

Methods are provided for the epigenetic analysis of cell-free DNA using organic boranes to convert oxidized 5-methylcytosine residues in the cell-free DNA to dihydrouracil (DHU) residues. Cell-free DNA is contacted with an organic borane selected to successively bring about reduction, deamination, and decarboxylation of oxidized 5-methylcytosine residues such as 5-carboxylcytosine and 5-formylcytosine, resulting in DHU residues in place thereof. Following amplification, the treated cell-free DNA is sequenced, with the DHU residues read as thymine residues. Reaction mixtures, kits and additional methods are also provided, as are related methods for the epigenetic analysis of DNA, including cell-free DNA.


Find Patent Forward Citations

Loading…